Current biomarkers and treatment strategies in Alzheimer disease: An overview and future perspectives
Alzheimer's disease (AD), a progressive degenerative disorder first identified by Alois Alzheimer in 1907, poses a significant public health challenge. Despite its prevalence and impact, there is currently no definitive ante mortem diagnosis for AD pathogenesis. By 2050, the United States may f...
Main Authors: | Ritesh P. Bhole, Rupesh V. Chikhale, Karishma M. Rathi |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2024-06-01
|
Series: | IBRO Neuroscience Reports |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2667242123022819 |
Similar Items
-
Rational drug repurposing for alzheimer’s treatment using in-silico ligand and structure-based approaches
by: Karishma Rathi, et al.
Published: (2024-02-01) -
Bioinformatic prediction of the molecular links between Alzheimer’s disease and diabetes mellitus
by: Ricardo Castillo-Velázquez, et al.
Published: (2023-02-01) -
Emerging drugs and targets for Alzheimer's disease /
by: Martn̕ez, Ana, 1961-, et al.
Published: (c201) -
Cerebrospinal Fluid Biomarkers of Alzheimer’s Disease: Current Evidence and Future Perspectives
by: Donovan A. McGrowder, et al.
Published: (2021-02-01) -
Use of Biomarkers in Ongoing Research Protocols on Alzheimer’s Disease
by: Marco Canevelli, et al.
Published: (2020-07-01)